LinkedIn
12 Jul

This NAIDOC Week, we honour the 2025 theme "The Next Generation: Strength, Vision & Legacy". Some of our activities and celebrations have included: Belle Hart, a proud Aboriginal woman, pharmacist and Victorian Program Coordinator for the Australian Alliance for Indigenous Genomics \@ WEHI, came and spoke to us about inclusive genomics and the importance of co-design in research. At our Broadmeadows manufacturing site, two walking paths were named in Woi Wurrung language with permission from the Wurundjeri Woi Wurrung Cultural Heritage Aboriginal Corporation. • barrawarn djinang – Magpies Footpath • wurun yana – Manna Gum Walk Many CSL employees have marked the week by attending local events, celebrations and educational sessions. Some visited the phenomenal “65,000 Years: A Short History of Australian Art” exhibition at the \@Potter Museum of Art, \@University of Melbourne – we highly recommend it. CSL remains committed to reconciliation and learning from, listening to and celebrating First Nations peoples, whose cultures, histories and contributions continue to enrich our communities and shape our shared future.

LinkedIn
10 Jul

CSL’s 32,000+ employees across 100+ countries are united by one mission: delivering innovative therapies that improve lives. #CSL #GlobalHealth #InnovationForLife https://bit.ly/4nXXlpZ

LinkedIn
9 Jul

CSL recently made an announcement about a new monoclonal antibody treatment. But what exactly are monoclonal antibodies? https://bit.ly/3IiugoA

LinkedIn
4 Jul

CSL was pleased to participate in and host a symposium at last week's Health Technology Assessment international (HTAi) annual meeting in Buenos Aires, Argentina. We joined fellow experts in discussing the essential role of plasma-derived medicinal products (PDMPs). Experts agreed that a resilient supply of PDMPs is a major imperative for patients of today and the future, recognizing that detrimental cost-containment policies and public procurement systems which prioritize price only, risk undermining the economic viability of these therapies with negative impacts over time. The unique nature of PDMPs — with the starting material coming from donated human blood plasma — combined with growing clinical demand, requires a thoughtful, tailored and multipronged policy approach. Better solutions are needed to ensure sustainable, steady supply and patient access. This symposium was a valuable opportunity to share insights about this special value chain and what it means for appropriate value recognition and access. At CSL, we are committed to enhancing and refining processes and policies to ensure reliable and sustainable access to PDMPs, which can ultimately contribute to better patient outcomes and alleviate pressure on healthcare systems. This is a core element of our promise to patients and the communities we serve. #HTAi2025 #PlasmaDerivedMedicinesProducts #PDMPs

LinkedIn
3 Jul

💡 What if a congress booth could help change the world? At CSL Vifor, we believe every step matters — and that includes how we show up at congresses. This year at ERA, we were proud to be recognized as part of the association’s first-ever Green Meeting Certificate. It’s a clear signal that sustainability is becoming a shared priority across the industry. Our contribution? ✔️ A sustainable, modular, and reusable booth ✔️ A no-paper approach — everything available via QR code ✔️ A mindset of “not built to be destroyed” It’s all part of our long-term strategy to make kidney care — and the planet — better, one step at a time. 👉 Driven by our promise to improve kidney care, we’re committed to rethinking not just treatments, but how we engage. #SustainabilityInAction #CSLVifor #ERA2025 #GreenMeetings #OneStepAtATime #KidneyCare

LinkedIn
2 Jul

Sustainability means more than reducing our footprint. At CSL, it also means expanding access to our therapies, supporting community health programs and partnering with organizations that improve care for those who need it most. Providing better care for brighter days ahead. #PromisingFutures #CSL Join us: https://bit.ly/4knsnnP